Loading...
XNAS
MMED
Market cap6.32bUSD
Sep 11, Last price  
22.50USD
1D
0.27%
1Q
48.42%
IPO
25.00%
Name

MiniMed Group Inc

Chart & performance

D1W1MN
XNAS:MMED chart
P/E
P/S
EPS
Div yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
3.10b
0.00%
2,245,000,0002,469,000,0002,715,000,0003,102,000,0003,102,000,000
Net income
-331m
L-0.00%
-96,000,000-112,000,000-250,000,000-331,000,000-331,000,000
CFO
-197m
L
-6,000,00041,000,000140,000,000-197,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

Related entities

Parent (2)
Medtronic Global Holdings S.C.A.
URL
IPO date
Mar 06, 2026
Employees
Domiciled in
US
Incorporated in
US
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Previous name
MDT Sub Holdings, Inc.
Previous name
Wallabies, Inc.

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFY
2026‑042026‑042025‑042024‑042023‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT